CeQur Simplicity is indicated for people with diabetes who require mealtime insulin. CeQur Simplicity has not been specifically studied in patients with Gestational Diabetes. However, Humalog and Novolog are approved for use in Gestational Diabetes.* Consult with your healthcare provider for more information.
- June, 2021CeQur Appoints Rick Doubleday and Dr. Meret Gaugler to Board of Directors
- April, 2021CeQur Raises $115 Million Series C5
- June, 2020“High Treatment Satisfaction with 3-day Insulin Patch is Independent of Patient Demographics: A Post-Hoc Analysis” — a presentation at the American Diabetes Association 80th Scientific Sessions
- June, 2019The Wider View: With new CEO in place, CeQur primed to PAQ a punch in diabetes market
- CeQur Appoints Bradley Paddock Chief Executive Officer